SEC Tracker
Get the app

Corcept Therapeutics CORT

Atabak Mokari (Officer) plans to sell 160,000 CORT shares, about $11.2M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Jun 1, 2026
  2. Broker: Stifel Nicolaus & Company Inc
  3. Shares acquired by: Stock Option Exercises
  4. 10b5-1 plan adopted: Dec 12, 2025

All of Atabak Mokari's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 40,000 shares at $70 on Jun 1, 2026 · Form 4
  • Sold 9,434 shares at $80.02 on Jun 15, 2026 · Form 4
  • Sold 11,081 shares at $80.94 on Jun 15, 2026 · Form 4
  • Sold 19,483 shares at $81.81 on Jun 15, 2026 · Form 4
  • Sold 2 shares at $82.45 on Jun 15, 2026 · Form 4
  • Sold 7,919 shares at $86.78 on Jul 15, 2026 · Form 4
  • Sold 28,460 shares at $87.89 on Jul 15, 2026 · Form 4
  • Sold 3,520 shares at $88.3 on Jul 15, 2026 · Form 4
  • Sold 101 shares at $89.43 on Jul 15, 2026 · Form 4
  • Sold 4,200 shares at $105.54 on Jul 30, 2026 · Form 4
  • Sold 8,956 shares at $106.96 on Jul 30, 2026 · Form 4
  • Sold 400 shares at $108.46 on Jul 30, 2026 · Form 4
  • Sold 2,202 shares at $110.03 on Jul 30, 2026 · Form 4
  • Sold 600 shares at $110.95 on Jul 30, 2026 · Form 4
  • Sold 4,700 shares at $113.18 on Jul 30, 2026 · Form 4
  • Sold 15,477 shares at $114.96 on Jul 30, 2026 · Form 4
  • Sold 4,783 shares at $118.73 on Jul 30, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Corcept Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Repligen RGEN public float $6.0B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  4. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  5. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.